Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065

Open AIDS Journal

Volumn 6, Issue SPEC.ISSUE 1, 2012, Pages 122-130

  Donnell, Deborah J ^a   Irene Hall, H ^b   Gamble, Theresa ^c   Beauchamp, Geetha ^a   Griffin, Angelique B ^d   Torian, Lucia V ^e   Branson, Bernard ^b   El Sadr, Wafaa M ^f  

^a USA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d District of Columbia Department of Health   (United States)

^e Department of Health and Mental Hygiene in the HIV   (United States)

^f ICAP Columbia University and Harlem Hospital New York ^*  (United States)

Author keywords

HIV; Linkage to care; Site randomized; Surveillance; Test and treat; Viral load suppression

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; COMMUNITY ASSESSMENT; COMMUNITY PROGRAM; CONTROL STRATEGY; FEASIBILITY STUDY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; POPULATION RESEARCH; PREVENTION STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; UNITED STATES; VIRUS INHIBITION;

EID: 84871030581     PISSN: None     EISSN: 18746136     Source Type: Journal    
DOI: 10.2174/1874613601206010122     Document Type: Article

References (29)

1. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23(11): 1397-404.
2. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375(9731): 2092-8.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365(6): 493-505.
4. Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S. Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001; 15(10): 1287-94.
5. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000; 287(5453): 650-4.
6. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373(9657): 48-57.
7. Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 198(1): 59-67.
8. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009; 301(22): 2380-2.
9. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of highrisk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39(4): 446-53.
10. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007; 21(4): 501-7.
11. Vergidis PI, Falagas ME, Hamer DH. Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. Infect Dis Clin North Am 2009; 23(2): 295-308.
12. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 2010; 53(5): 619-24.
13. Vital signs: HIV testing and diagnosis among adults-United States, 2001-2009. MMWR Morb Mortal Wkly Rep 2010; 59(47): 1550-5.
14. HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57(39): 1073-6.
15. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008; 168(11): 1181-7.
16. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 2007; 44(11): 1493-9.
17. Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care STDS 2011; 25(2): 79-88.
18. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS 2010; 24(17): 2665-78.
19. Zetola NM, Bernstein K, Ahrens K, et al. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health 2009; 9: 17.
20. Meyerson BE, Klinkenberg WD, Perkins DR, Laffoon BT. Who's in and who's out: use of primary medical care among people living with HIV. Am J Public Health 2007; 97(4): 744-9.
21. Torian LV, Henning KJ, Kellerman SE, Frieden TR. Striving toward comprehensive HIV/AIDS surveillance: the view from New York City. Public Health Rep 2007; 122(Suppl 1): 4-6.
22. Hayes RJ, Moulton L. Cluster Randomised Trials. UK: Chapman & Hall/CRC Interdisciplinary Statistics 2009.
23. Hayes RJ, Bennett S. Simple sample size calculation for clusterrandomized trials. Int J Epidemiol 1999; 28(2): 319-26.
24. Thomson A, Hayes R, Cousens S. Measures of between-cluster variability in cluster randomized trials with binary outcomes. Stat Med 2009; 28(12): 1739-51.
25. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5(6): e11068.
26. Des Jarlais DC, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007; 21(2): 231-5.
27. Donnell D, Hughes JP, Fleming TR. Challenges in the design of HIV prevention trials in the United States. J Acquir Immune Defic Syndr 2010; 55(S2): S136-S40.
28. Hughes JP. Using baseline data to design a group randomized trial. Stat Med 2005; 24(13): 1983-94.
29. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55(RR-14): 1-17.